Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexaria Bioscience Corp

0.9900
+0.01351.38%
Volume:30.06K
Turnover:29.68K
Market Cap:19.29M
PE:-1.68
High:1.02
Open:0.9700
Low:0.9500
Close:0.9765
Loading ...
OverviewCompanyNewsFilings

Lexaria Bioscience Corp expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
09 Jan

Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright

TIPRANKS
·
21 Dec 2024

Lexaria Bioscience Initiates Promising Drug Study

TIPRANKS
·
20 Dec 2024

Lexaria Bioscience begins dosing for GLP-1 study #4

TIPRANKS
·
19 Dec 2024

Lexaria's Registered GLP-1 Study #4 Begins Dosing

ACCESSWIRE
·
19 Dec 2024

BRIEF-Lexaria Bioscience Says Unit Finalizes Project Agreement With Novotech

Reuters
·
19 Dec 2024

Lexaria Bioscience Corp - Unit Finalizes Project Agreement With Novotech

THOMSON REUTERS
·
19 Dec 2024

Lexaria Bioscience Bolsters Drug Delivery Strategy

TIPRANKS
·
19 Dec 2024

Lexaria Bioscience forms Scientific Advisory Board

TIPRANKS
·
18 Dec 2024

Lexaria Forms New Scientific Advisory Board

ACCESSWIRE
·
18 Dec 2024

Lexaria Bioscience Welcomes New Chief Medical Advisor

TIPRANKS
·
18 Dec 2024

Lexaria Bioscience appoints Michael Gibson as chief medical advisor

TIPRANKS
·
17 Dec 2024

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

ACCESSWIRE
·
17 Dec 2024

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Apr 14, 2025
Financial Report Announcement
Jan 10, 2025
Financial Report Announcement
Nov 26, 2024
Financial Report Announcement
Jul 12, 2024
Financial Report Announcement
Apr 09, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.12
Current
-5.34
Sector Average
78.92%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.12
Maximum
-0.68
+1 STD
-1.80
Minimum
-15.58
-1 STD
-8.87
Average
-5.34

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.